Tham khảo Radotinib

  1. ↑ Joanne Bronson; Amelia Black; T. G. Murali Dhar; Bruce A. Ellsworth; J. Robert Merritt. “Radotinib (Anticancer)”. Annual Reports in Medicinal Chemistry. 48: 523–524. doi:10.1016/b978-0-12-417150-3.00028-4. |chapter= bị bỏ qua (trợ giúp)
  2. ↑ http://www.ilyang.co.kr/english/rnd/rnd03.asp
  3. ↑ http://www.dailypharm.com/Users/News/EnglishNews.html?NewsID=3108&nStart=1023&mode=&searchValue=
  4. ↑ Kim SH, Menon H, Jootar S, Saikia T, Kwak JY, Sohn SK, Park JS, Jeong SH, Kim HJ, Kim YK, Oh SJ, Kim H, Zang DY, Chung JS, Shin HJ, Do YR, Kim JA, Kim DY, Choi CW, Park S, Park HL, Lee GY, Cho DJ, Shin JS, Kim DW (2014). “Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors”. Haematologica. 99: 1191–6. doi:10.3324/haematol.2013.096776. PMC 4077080. PMID 24705186.
  5. ↑ https://clinicaltrials.gov/ct2/show/NCT01511289?term=radotinib&rank=1
  6. ↑ “Radotinib hydrochloride”. NCI Drug Dictionary. National Cancer Institute.

Liên quan

Tài liệu tham khảo

WikiPedia: Radotinib http://www.chemspider.com/Chemical-Structure.17222... http://www.dailypharm.com/Users/News/EnglishNews.h... //edwardbetts.com/find_link?q=Radotinib http://www.cancer.gov/drugdictionary?cdrid=723999 //pubmed.ncbi.nlm.nih.gov/24705186 //www.ncbi.nlm.nih.gov/pmc/articles/PMC4077080 http://www.ilyang.co.kr/english/rnd/rnd03.asp http://www.commonchemistry.org/ChemicalDetail.aspx... //doi.org/10.1016%2Fb978-0-12-417150-3.00028-4 //doi.org/10.3324%2Fhaematol.2013.096776